These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 17673493

  • 1. Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis.
    Lin X, Tench CR, Morgan PS, Constantinescu CS.
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):437-41. PubMed ID: 17673493
    [Abstract] [Full Text] [Related]

  • 2. 'Importance sampling' in MS: use of diffusion tensor tractography to quantify pathology related to specific impairment.
    Lin X, Tench CR, Morgan PS, Niepel G, Constantinescu CS.
    J Neurol Sci; 2005 Oct 15; 237(1-2):13-9. PubMed ID: 16109428
    [Abstract] [Full Text] [Related]

  • 3. The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.
    Caligiuri ME, Barone S, Cherubini A, Augimeri A, Chiriaco C, Trotta M, Granata A, Filippelli E, Perrotta P, Valentino P, Quattrone A.
    Neuroimage Clin; 2015 Oct 15; 7():28-33. PubMed ID: 25610764
    [Abstract] [Full Text] [Related]

  • 4. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R, De Masi R, Nasuelli D, Bragadin LM, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M.
    Neuroradiology; 2001 Apr 15; 43(4):272-8. PubMed ID: 11338408
    [Abstract] [Full Text] [Related]

  • 5. Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
    Barone S, Caligiuri ME, Valentino P, Cherubini A, Chiriaco C, Granata A, Filippelli E, Tallarico T, Nisticò R, Quattrone A.
    J Neurol; 2018 Oct 15; 265(10):2243-2250. PubMed ID: 30051273
    [Abstract] [Full Text] [Related]

  • 6. Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients.
    Hasan KM, Gupta RK, Santos RM, Wolinsky JS, Narayana PA.
    J Magn Reson Imaging; 2005 Jun 15; 21(6):735-43. PubMed ID: 15906348
    [Abstract] [Full Text] [Related]

  • 7. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O'Connor MF, Sicotte NL.
    Neuroimage Clin; 2015 Jun 15; 8():440-7. PubMed ID: 26106524
    [Abstract] [Full Text] [Related]

  • 8. Diffusion tensor imaging of corpus callosum integrity in multiple sclerosis: correlation with disease variables.
    Sigal T, Shmuel M, Mark D, Gil H, Anat A.
    J Neuroimaging; 2012 Jan 15; 22(1):33-7. PubMed ID: 21122007
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G, COGIMUS Study Group.
    Mult Scler; 2009 Jul 15; 15(7):779-88. PubMed ID: 19542262
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
    Oreja-Guevara C, Charil A, Caputo D, Cavarretta R, Sormani MP, Filippi M.
    Arch Neurol; 2006 May 15; 63(5):736-40. PubMed ID: 16682543
    [Abstract] [Full Text] [Related]

  • 14. Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis.
    Sánchez MP, Nieto A, Barroso J, Martín V, Hernández MA.
    Eur J Neurol; 2008 Oct 15; 15(10):1091-9. PubMed ID: 18727673
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis.
    Deloire MS, Salort E, Bonnet M, Arimone Y, Boudineau M, Amieva H, Barroso B, Ouallet JC, Pachai C, Galliaud E, Petry KG, Dousset V, Fabrigoule C, Brochet B.
    J Neurol Neurosurg Psychiatry; 2005 Apr 15; 76(4):519-26. PubMed ID: 15774439
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Corpus callosum damage and cognitive dysfunction in benign MS.
    Mesaros S, Rocca MA, Riccitelli G, Pagani E, Rovaris M, Caputo D, Ghezzi A, Capra R, Bertolotto A, Comi G, Filippi M.
    Hum Brain Mapp; 2009 Aug 15; 30(8):2656-66. PubMed ID: 19067325
    [Abstract] [Full Text] [Related]

  • 20. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
    De Stefano N, Battaglini M, Stromillo ML, Zipoli V, Bartolozzi ML, Guidi L, Siracusa G, Portaccio E, Giorgio A, Sorbi S, Federico A, Amato MP.
    Brain; 2006 Aug 15; 129(Pt 8):2008-16. PubMed ID: 16815879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.